Literature DB >> 9089643

Increase in transglutaminase and its extracellular products in response to an inflammatory stimulus by lipopolysaccharide.

J M Bowness1, A H Tarr.   

Abstract

Transglutaminase (TGase) activities were measured in rat tissues 1-7 days after intraperitoneal injection of saline or lipopolysaccharide (LPS) and in the cells and media from pre-confluent human fibroblasts cultured for two days in the presence or absence of LPS. epsilon (gamma-Glutamyl)lysine and [3H]putrescine-labelled gamma-glutamyl derivatives in extracellular and cellular fibroblast proteins were also measured. Three effects of LPS were observed. Firstly, total TGase activity is greater in the tissues from the LPS-injected animals, with the maximum increase occurring at 1 day in dermis, epidermis and liver, at 5 days in the aorta and, after a decrease at 2-5 days, at 7 days in the panniculus muscle. Secondly, the fraction of the total activity which is buffer-extractable is greater on days 1 and/or 2 in all the tissues from the LPS-injected rats. Thirdly, in cultures of human fibroblasts, LPS increases that fraction of bound [3H]putrescine and of TGase and its gamma-glutamylamine products which occurs in the extracellular medium. In addition, a higher concentration of TGase-derived crosslinks was found in extracellular as opposed to intracellular proteins. In conjunction with previous findings in skin wound healing and in atherosclerosis these results support the concept of an extracellular function for tissue TGase and indicate that there is a widespread association of increases in TGase and its extracellular products with inflammation and the healing or fibrotic processes which follow it.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089643     DOI: 10.1023/a:1006846400478

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  22 in total

1.  Detection of epsilon(gamma-glutamyl) lysine.

Authors:  M Griffin; J Wilson
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 2.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

3.  Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.

Authors:  J B Weinberg; A M Pippen; C S Greenberg
Journal:  Arthritis Rheum       Date:  1991-08

4.  Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells.

Authors:  J P Kleman; D Aeschlimann; M Paulsson; M van der Rest
Journal:  Biochemistry       Date:  1995-10-24       Impact factor: 3.162

5.  Inflammation and coronary artery disease.

Authors:  R W Alexander
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

6.  Increased epsilon(gamma-glutamyl)lysine crosslinking associated with increased protein synthesis in the inner layers of healing rat skin wounds.

Authors:  J M Bowness; S Sewell; A H Tarr
Journal:  Biochim Biophys Acta       Date:  1992-06-12

7.  High-performance liquid chromatographic method for the determination of epsilon-(gamma-glutamyl)lysine and mono- and bis-gamma-glutamyl derivatives of putrescine and spermidine.

Authors:  S Beninati; N Martinet; J E Folk
Journal:  J Chromatogr       Date:  1988-06-29

8.  Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria.

Authors:  M C Leeson; Y Fujihara; D C Morrison
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen.

Authors:  J M Bowness; J E Folk; R Timpl
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

10.  Effect of putrescine on tissue transglutaminase activity in wounds: decreased breaking strength and increased matrix fucoprotein solubility.

Authors:  K N Dolynchuk; R Bendor-Samuel; J M Bowness
Journal:  Plast Reconstr Surg       Date:  1994-03       Impact factor: 4.730

View more
  7 in total

1.  Characterization of transglutaminase type II role in dendritic cell differentiation and function.

Authors:  Ivana Matic; Alessandra Sacchi; Alessandra Rinaldi; Gennaro Melino; Chaitan Khosla; Laura Falasca; Mauro Piacentini
Journal:  J Leukoc Biol       Date:  2010-04-06       Impact factor: 4.962

2.  A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor.

Authors:  Joonhong Sohn; Ju Byung Chae; Sun Young Lee; Soo-Youl Kim; June-Gone Kim
Journal:  Korean J Ophthalmol       Date:  2010-02-05

Review 3.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

4.  The proinflammatory protein HMGB1 is a substrate of transglutaminase-2 and forms high-molecular weight complexes with autoantigens.

Authors:  William L Willis; Linan Wang; Takuma Tsuzuki Wada; Mark Gardner; Omar Abdouni; Jeffrey Hampton; Giancarlo Valiente; Nicholas Young; Stacy Ardoin; Sudha Agarwal; Michael A Freitas; Lai-Chu Wu; Wael N Jarjour
Journal:  J Biol Chem       Date:  2018-04-04       Impact factor: 5.157

5.  Upregulation of transglutaminase and ε (γ-glutamyl)-lysine in the Fisher-Lewis rat model of chronic allograft nephropathy.

Authors:  Badri Shrestha; Imran Butt; Michelle Da Silva; Armando Sanchez-Lara; Bart Wagner; Andrew Raftery; Timothy Johnson; John Haylor
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

6.  Cementoin-SLPI fusion protein binds to human monocytes and epithelial cells and shows higher biological activity than SLPI.

Authors:  Paulo C Maffía; Diego Guerrieri; Ximena Villalonga; Fiorella Caro; Sonia Gómez; Nancy Tateosian; Betiana P Bogado; Mercedes L Sánchez; Nella Ambrosi; Eduardo Chuluyan
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

7.  Resolution of Eczema with Multivalent Peptides.

Authors:  Laura L Eggink; J Kenneth Hoober
Journal:  JID Innov       Date:  2022-07-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.